Hartley-Blossom Z, Cardona-Del Valle A, Muns-Aponte C, Udayakumar N, Carlos RC, Flores EJ. Advancing Health Equity in Lung Cancer Screening and the Role of Humanomics.
Thorac Surg Clin 2023;
33:365-373. [PMID:
37806739 PMCID:
PMC10622157 DOI:
10.1016/j.thorsurg.2023.04.007]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/10/2023]
Abstract
Identifying and managing lung cancer, the leading cause of cancer-specific mortality, depend on multiple medical and sociodemographic factors. Humanomics is a model that acknowledges that negative societal stressors from systemic inequity affect individual health by altering pro-inflammatory gene expression. The same factors which may predispose individuals to lung cancer may also obstruct equitably prompt diagnosis and treatment. Increasing lung cancer screening access can lessen disparities in outcomes among disproportionately affected communities. Here, the authors describe several individual, provider, and health system-level obstacles to lung cancer screening and offer actionable solutions to increase access.
Collapse